Jump to content

Biologika und Biosimilars

  • entries
    19
  • comments
    6
  • views
    16,209

Studie zu Secukinumab (Cosentyx) bei Psoriasis (Schuppenflechte)-Arthritis


GrBaer185

1,183 views

 Share

Aktuell (Jan. 2023) werden Teilnehmer an einer Vergleichsstudie zur Therapie der Psoriasis Arthritis mit Secukinumab bzw. Ustekinumab gesucht.
Näheres dazu:
Psoriasis-Arthritis - Novartis – Klinische Forschung
oder
https://klinischeforschung.novartis.de/doctor/psoriasis-arthritis-studie-cain457fde04-again/

 Share

0 Comments


Recommended Comments

There are no comments to display.

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Add a comment...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


Willkommen

Willkommen in der Community für Menschen mit Schuppenflechte und Psoriasis arthritis. Ohne Werbung, ohne Tracking, aber mit ganz viel Herz 💛

×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.